FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$3.34B
1-Year Est. Return
92.56%
1 Year Est. Return
+92.56%
AUM
$2.5B
AUM Growth
+$313M
(+14%)
Holding
55
Top Buys
| 1 | +$33.5M | |
| 2 | +$31.9M | |
| 3 | +$22.6M | |
| 4 |
Evolus
EOLS
|
+$22.4M |
| 5 |
Akero Therapeutics
AKRO
|
+$19.6M |
Top Sells
| 1 | +$36M | |
| 2 | +$35.7M | |
| 3 | +$15.7M | |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$7.81M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
+$7.2M |
Sector Composition
| 1 | Healthcare | 99.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Immatics
IMTX
$1.24B
| – | – |
-1,247,911
|
|
||
52
Merus
MRUS
$7.28B
| – | – |
-373,100
|
|
||
|
53
Rocket Pharmaceuticals
RCKT
$330M
| – | – |
-1,079,025
|
|
||
54
Rhythm Pharmaceuticals
RYTM
$6.63B
| – | – |
-678,760
|
|
||
55
Soleno Therapeutics
SLNO
$2.65B
| – | – |
-499,159
|
|